Luceome Biotechnologies
About:
Luceome Biotechnologies is an biotechnology company that uses assay technology for identification of drugs against kinases.
Website: https://www.luceome.com/
Top Investors: National Institutes of Health
Description:
Luceome Biotechnologies offers cell-based and in vitro kinase assay services for drug discovery using its hybrid split-luciferase technology. They provide assay solutions that are based on a technology platform that utilises luciferase fragment complementation.
Total Funding Amount:
$1.9M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Tucson, Arizona, United States
Founded Date:
2007-01-01
Contact Email:
info(AT)luceome.com
Founders:
Indraneel Ghosh
Number of Employees:
1-10
Last Funding Date:
2011-08-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai